Business Opportunities

Unichem Labs gets USFDA nod for hypertension tablets

Pharma firm Unichem Laboratories today said it has received US regulatory approval for Clonidine Hydrochloride tablets USP used in the treatment of hypertension. - Ranbaxy receives final USFDA approval for Glycopyrolate - India to export fresh litchi to US for first time - After mangoes, India to export litchis to US - Ranbaxy, Aurobindo get USFDA nod for migraine drug - Sun Pharma settles patent dispute with Astra Zeneca - Daiichi wins court battle against Mylan, Matrix The company has received Abbreviated New Drug Application (ANDA) approval from the United States Food and Drug Administration (USFDA)for the tablets, Unichem Laboratories said in a filing to the BSE. The tablets are in the strength of 0.1mg, 0.2mg and 0.3mg.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
All is Greenberg
Enough has been written about last year’s collapse of insurance giant AIG after it had to make good all the insurance it sold against corporate bond defaults and the fact that the US government bailout happened to help Goldman Sachs, the firm that US Treasury Secretary Hank Paulson once ran. Much less, however, is known about the company’s origins (it was the first reverse MNC, with its headquarters in China), of how it had such tremendous clout it could even threaten governments with US sanctions, or of how in the second World War it allowed US intelligence agency officials to masquerade as journalists of one of the newspapers it owned and collect information against the Japanese.
Popular Articles
payday loan lenders

Posco gets final nod from Environment Min
South Korean steel giant Posco has finally got the clearance from the Environment Ministry for acquiring forest land for its proposed Rs 54,000-crore steel project in Orissa, which has been already delayed more than a year.

India topped project finance deals in 2009
SBI Caps heads global loan chart; power sector dominates.